FI923797A - N-substituerade aminometandifosfonsyror - Google Patents

N-substituerade aminometandifosfonsyror Download PDF

Info

Publication number
FI923797A
FI923797A FI923797A FI923797A FI923797A FI 923797 A FI923797 A FI 923797A FI 923797 A FI923797 A FI 923797A FI 923797 A FI923797 A FI 923797A FI 923797 A FI923797 A FI 923797A
Authority
FI
Finland
Prior art keywords
aminometandiposphosfonsyror
substituerade
alk1
disorders
chem
Prior art date
Application number
FI923797A
Other languages
English (en)
Other versions
FI923797A0 (fi
Inventor
Knut Alfred Jaeggi
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI923797A0 publication Critical patent/FI923797A0/fi
Publication of FI923797A publication Critical patent/FI923797A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Dental Preparations (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI923797A 1991-08-27 1992-08-24 N-substituerade aminometandifosfonsyror FI923797A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91810682 1991-08-27

Publications (2)

Publication Number Publication Date
FI923797A0 FI923797A0 (fi) 1992-08-24
FI923797A true FI923797A (fi) 1993-02-28

Family

ID=8208873

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923797A FI923797A (fi) 1991-08-27 1992-08-24 N-substituerade aminometandifosfonsyror

Country Status (19)

Country Link
US (1) US5281748A (fi)
EP (1) EP0531253B1 (fi)
JP (1) JPH05222074A (fi)
KR (1) KR930004317A (fi)
AT (1) ATE147396T1 (fi)
AU (1) AU657983B2 (fi)
CA (1) CA2076801A1 (fi)
DE (1) DE69216514T2 (fi)
DK (1) DK0531253T3 (fi)
ES (1) ES2096061T3 (fi)
FI (1) FI923797A (fi)
GR (1) GR3022243T3 (fi)
HU (1) HUT62303A (fi)
IL (1) IL102959A (fi)
MX (1) MX9204905A (fi)
NO (1) NO923331L (fi)
NZ (1) NZ244078A (fi)
TW (1) TW207543B (fi)
ZA (1) ZA926434B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0541037A3 (en) * 1991-11-06 1997-02-26 Takeda Chemical Industries Ltd Squalene synthetase inhibitory composition and use thereof
TW258729B (fi) * 1992-06-22 1995-10-01 Ciba Geigy
DE4223940A1 (de) * 1992-07-21 1994-01-27 Boehringer Mannheim Gmbh Neue acyclische Amidingruppen-haltige Diphosphonsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
GB9300641D0 (en) * 1993-01-14 1993-03-03 Zeneca Ltd Process
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
IT1303672B1 (it) 1998-07-28 2001-02-23 Nicox Sa Sali nitrati di farmaci attivi nei disordini ossei

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2316396C3 (de) * 1973-04-02 1975-09-18 Joh. A. Benckiser Gmbh, 6700 Ludwigshafen N(1,1-Di-phosphono-äthyl)acetamidin, seine Herste lung und Verwendung zur Steinverhütung
DE3208600A1 (de) * 1982-03-10 1983-09-22 Henkel KGaA, 4000 Düsseldorf Amidinodiphosphonsaeuren
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4963681A (en) * 1987-07-06 1990-10-16 Norwich Eaton Pharmaceuticals, Inc. Process for synthesis of aminomethylene phosphonoalkylphosphinates
PH26923A (en) * 1989-03-08 1992-12-03 Ciba Geigy N-substituted amino alkanediphosphonic acids
IE912115A1 (en) * 1990-06-25 1992-01-01 Takeda Chemical Industries Ltd Bisphosphonic acid derivatives, their production and use
US5043099A (en) * 1990-07-13 1991-08-27 Kreh Robert P Mono- and di-substituted (diphosphonoalkylamino methyl)-4-hydroxybenzenesulfonic acid
IE914417A1 (en) * 1990-12-19 1992-07-01 Takeda Chemical Industries Ltd Bisphosphonic acid derivatives, their production and use

Also Published As

Publication number Publication date
DK0531253T3 (da) 1997-01-27
US5281748A (en) 1994-01-25
IL102959A (en) 1998-01-04
HU9202754D0 (en) 1992-12-28
EP0531253A1 (en) 1993-03-10
NO923331D0 (no) 1992-08-26
IL102959A0 (en) 1993-01-31
DE69216514T2 (de) 1997-07-31
ZA926434B (en) 1993-04-28
JPH05222074A (ja) 1993-08-31
AU657983B2 (en) 1995-03-30
HUT62303A (en) 1993-04-28
DE69216514D1 (de) 1997-02-20
ATE147396T1 (de) 1997-01-15
CA2076801A1 (en) 1993-02-28
FI923797A0 (fi) 1992-08-24
KR930004317A (ko) 1993-03-22
MX9204905A (es) 1993-04-01
ES2096061T3 (es) 1997-03-01
NZ244078A (en) 1994-12-22
GR3022243T3 (en) 1997-04-30
EP0531253B1 (en) 1997-01-08
TW207543B (fi) 1993-06-11
AU2128892A (en) 1993-03-04
NO923331L (no) 1993-03-01

Similar Documents

Publication Publication Date Title
NO940038D0 (no) Arylsulfonamido-substituerte hydrokamsyrer
MC2195A1 (fr) Derives d'acides amines
FI915920A0 (fi) Serotoninantagonister.
NO924915L (no) Sakkarinderivater med inhiberende virkning paa protolytiske enzymer
DE68914292T2 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
DE69623899D1 (de) Behandlung von Tinnitus mit neuroprotektiven Wirkstoffen
DE69716810T2 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
NO307464B1 (no) Galantaminderivater, farmasøytisk sammensetning inneholdende samme samt deres anvendelse for fremstilling av medikamenter
FI903994A0 (fi) Menetelmä valmistaa farmakologisesti arvokkaita 2-(RS)-substituoituja 2,3-dihydro-5-oksi-4,6,7-trimetyylibentsofuraaneja
ATE147396T1 (de) N-substituierte aminomethandiphosphonsäuren
DK0610078T3 (da) Cytotoksisk og antiviral forbindelse.
ES2088903T3 (es) Nuevos inhibidores de la s-adenosilmetionina descarboxilasa.
DE3880304D1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central
ATE81971T1 (de) Synergistische kombination von decarboxylasehemmern und l-dopa-pellets.

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FD Application lapsed